Skip to main content

New Product

Premium

Waters this week introduced a new UPLC analytical solution for the characterization of 2-AB labeled glycans from glycoproteins.

The solution combines new Acquity UPLC BEH Glycan columns with the Acquity UPLC system equipped with fluorescence detection.

In a statement, Waters said the solution is being introduced at the request of scientists who want to apply UPLC technology to the development and analysis of glycans derived from therapeutic proteins. Regulations from the US Food and Drug Administration require that companies developing and manufacturing therapeutic proteins be able to accurately characterize the glycan attached to those proteins in order to ensure efficacy and safety of a biopharmaceutical product.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.